Home/SEC 13D/G/SLSSEC 13D/G$SLS SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks Simplified$SLS$10.37▲ 139.49% YTDHealthcareJul 31, 2026 · ThinkSabio BlogSEC Filing Update: #SLS : $10.37 Sector: Healthcare | YTD: 🔼+ 139.49% The SEC disclosed Today (31-JUL-2026) that Vanguard Capital Management has INCREASED #SLS Shares by 28.44% 🟢 * Previous Holdings: 7.53M Shares * Current Holdings: 9.67M Shares * Increase+2.14M * Increased(%)+28.44% * Ownership: 5.19% * Estimated Investment Value: $24.12M https://www.thinksabio.com/reports/isr/SLS Institutional ownership in #SLS has been steadily rising over the past 8 quarters in Shares: Q2 2024: 4.06M Q3 2024: 5.39M Q4 2024: 6.79M Q1 2025: 14.29M Q2 2025: 26.77M Q3 2025: 32.92M Q4 2025: 35.43M Q1 2026: 53.96M The quarterly average prices of #SLS: Q1 2025: $1.19 Q2 2025: $1.53 Q3 2025: $1.78 Q4 2025: $1.93 Q1 2026: $4.47 Share this post🔗Copy LinkMore filings for $SLSSLS - SELLAS Life Sciences Group, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G